We all have a number of genes, called tumour suppressor genes, that are involved in regulating cell growth and repairing cell damage. These genes form a natural defence system against cancer by ensuring our cells develop normally and are continuously maintained. BRCA1 and BRCA2 are part of that system.
Mutated BRCA genes lose their ability to repair cell damage. Woman who inherit a BRCA mutation have a higher risk of developing breast and ovarian cancer [80% and 40% respectively). Men who inherit a BRCA mutation have a higher risk of breast and prostate cancer.
Consultation Administration Logistics and Shipping fee: $NZD $395
Test fee: $USD 250.
Please note that testing is publicly funded for NZ patients if they meet eligibility criteria set by the New Zealand Genetic Health Service. Please ask your healthcare provider whether you may qualify for funded testing.
Turn around time is approximately 3 weeks. Invitae sends the result to Sequenca Genetics, who will forward the report to the requesting health provider.
Your health provider will refer you to Sequenca Genetics. We will go through pretest education and you then provide a saliva sample.
The sample is sent to Invitae in San Francisco, California. Invitae is CLIA certified and CAP accredited.